Evidence map›Paper›PMID 40785933›Full record

ArticleQuantitative imaging in medicine and surgery2025

Differentiation of dual- and non-dual-phenotype hepatocellular carcinoma based on contrast-enhanced computed tomography and patient characteristics.

Yunying Qin, Siyi Zhang, Xiangyang Huang, Ningbin Luo, Danke Su

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yunying Qin *Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Siyi Zhang *Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Xiangyang HuangDepartment of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Ningbin LuoDepartment of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Danke SuDepartment of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dual-phenotype hepatocellular carcinoma (DPHCC) is associated with a higher risk of recurrence, but little is known about its clinicodemographic characteristics or imaging features. This study aimed to assess whether contrast-enhanced computed tomography (CECT) and patient characteristics can facilitate preoperative differentiation of DPHCC and non-DPHCC. Methods: Features on CECT images and clinicodemographic characteristics were retrospectively analyzed from a consecutive series of hepatocellular carcinoma (HCC) patients between January 2020 and December 2020. Disease was confirmed based on surgical pathology, and CECT was performed within four weeks before surgery. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for DPHCC, and an imaging model based on CECT features and a combined model based on clinicodemographic characteristics and CECT features were constructed, respectively. Delong's test was used for comparison of the area under the curve (AUC) values between the two models. Kaplan-Meier survival analysis was used to assess overall survival (OS) in DPHCC and non-DPHCC groups. Results: A total of 29 patients with DPHCC and 140 with non-DPHCC were included in this study. DPHCC was significantly more prevalent among female patients and less prevalent among those infected with hepatitis B virus (HBV). CECT associated DPHCC with rim arterial phase hyperenhancement (APHE) and peripheral washout, whereas it associated non-DPHCC with non-rim APHE and non-peripheral washout. Multivariate logistic regression identified one independent CECT feature of DPHCC: rim APHE [odds ratio (OR) 11.040, 95% confidence interval (CI): 1.98-63.532]. The imaging model was constructed based on rim APHE-predicted DPHCC with an AUC of 0.562 (95% CI: 0.439-0.684). Multivariate logistic regression identified three independent clinicodemographic characteristics and CECT features of DPHCC: female sex (OR 4.519, 95% CI: 1.529-13.357), infection with HBV (OR 0.234, 95% CI: 0.084-0.654) and rim APHE (OR 15.016, 95% CI: 2.335-96.585). The combined model was constructed based on three independent predictors of DPHCC with an AUC of 0.716 (95% CI: 0.603-0.829). Delong's test showed that the AUC of the combined model was higher than that of the imaging model, and the difference was statistically significant (Z=3.207, P<0.05). The OS rates of the patients in the DPHCC and non-DPHCC groups were 68.7% and 77.2%, respectively. Kaplan-Meier survival analysis showed no statistical difference in OS rates between groups (P=0.362). Conclusions: The combined model established based on female sex, infection with HBV, and rim APHE by CECT can facilitate preoperative differentiation of DPHCC and non-DPHCC. DPHCC is more likely to cause death than non-DPHCC, suggesting that active postoperative management of patients with DPHCC is required.

Indexed as

Contrast-enhanced computed tomography (CECT)dual-phenotype hepatocellular carcinoma (DPHCC)non-dual-phenotype hepatocellular carcinoma (non-DPHCC)peripheral washoutrim arterial phase hyperenhancement

Identifiers

PMID40785933
PMCPMC12332666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.